104 related articles for article (PubMed ID: 429787)
1. Protection from natural infection after live influenza virus immunization in an open population.
Rocchi G; Carlizza L; Andreoni M; Ragona G; Piga C; Pelosio A; Volpi A; Muzzi A
J Hyg (Lond); 1979 Apr; 82(2):231-6. PubMed ID: 429787
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease.
Rocchi G; Ragona G; Piga C; Pelosio A; Volpi A; Vella S; Legniti N; de Felici A
J Hyg (Lond); 1979 Dec; 83(3):383-90. PubMed ID: 512351
[TBL] [Abstract][Full Text] [Related]
3. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
[TBL] [Abstract][Full Text] [Related]
4. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
[TBL] [Abstract][Full Text] [Related]
5. [Results of a study of the effectiveness of simultaneous immunization against influenza with live and inactivated vaccines (1980-1983)].
Zhilova GP; Ignat'eva GS; Orlov VA; Malikova EV; Maksakova VL
Vopr Virusol; 1986; 31(1):40-4. PubMed ID: 2938336
[TBL] [Abstract][Full Text] [Related]
6. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
[TBL] [Abstract][Full Text] [Related]
8. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy.
Rytel MW; Jackson LJ; Ferstenfeld JE; Rosenkranz MA
J Infect Dis; 1975 Dec; 132(6):652-9. PubMed ID: 1202110
[TBL] [Abstract][Full Text] [Related]
9. Protection by a polyvalent influenza vaccine and persistence of homologous and heterologous HI antibodies during a period of two epidemic seasons.
Pyhälä R
J Hyg (Lond); 1980 Apr; 84(2):237-45. PubMed ID: 7358963
[TBL] [Abstract][Full Text] [Related]
10. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated influenza virus vaccine trial in children.
Hall CB; Douglas G; Fralonardo SA
Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
14. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.
Clements ML; Makhene MK; Karron RA; Murphy BR; Steinhoff MC; Subbarao K; Wilson MH; Wright PF
J Infect Dis; 1996 Jan; 173(1):44-51. PubMed ID: 8537681
[TBL] [Abstract][Full Text] [Related]
15. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976.
Feery BJ; Evered MG; Morrison EI
J Infect Dis; 1979 Feb; 139(2):237-41. PubMed ID: 374644
[TBL] [Abstract][Full Text] [Related]
16. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
[TBL] [Abstract][Full Text] [Related]
17. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital.
Hoskins TW; Davies JR; Smith AJ; Miller CL; Allchin A
Lancet; 1979 Jan; 1(8106):33-5. PubMed ID: 83475
[TBL] [Abstract][Full Text] [Related]
18. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
Bruj J; Skocil V; Farník J; Hronovský F; Síp J
Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
[No Abstract] [Full Text] [Related]
19. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
[TBL] [Abstract][Full Text] [Related]
20. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
